AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32282927 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) with stent retrievers introduced in 2011
Number of subjects: 235
Study 32282927 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) with aspiration and stent retrievers introduced in 2012
Number of subjects: 235
Study 32282927 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) in 2018
Number of subjects: 235
Study 33142340 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolled subjects in the PREMOD2 trial
Number of subjects: 0
Study 33142340 — intervention group
Group type: EXPERIMENTAL
Intervention: Sites with waiver of consent
Number of subjects: 0
Study 33142340 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants approached for consent prior to delivery
Number of subjects: 0
Study 33480518 — intervention group
Group type: EXPERIMENTAL
Intervention: CON (concentric-only)
Number of subjects: 12
Study 33480518 — intervention group
Group type: EXPERIMENTAL
Intervention: ECC (eccentric-only)
Number of subjects: 12
Study 33480518 — intervention group
Group type: EXPERIMENTAL
Intervention: CON-ECC (alternated concentric followed by eccentric)
Number of subjects: 12
Study 33480518 — intervention group
Group type: EXPERIMENTAL
Intervention: ECC-CON (alternated eccentric followed by concentric)
Number of subjects: 12
Study 33480518 — intervention group
Group type: COMPARATOR
Intervention: CON-ECC
Number of subjects: 12
Study 34773094 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS (2.510 MJ)
Number of subjects: 21
Study 34773094 — intervention group
Group type: COMPARATOR
Intervention: PLACEBO (0.377 MJ)
Number of subjects: 21
Study 33247344 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin for 3 months
Number of subjects: 180
Study 33247344 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 180
Study 33621631 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency spinal cord stimulation (SCS)
Number of subjects: 0
Study 33621631 — intervention group
Group type: COMPARATOR
Intervention: Burst spinal cord stimulation (SCS)
Number of subjects: 0
Study 35720883 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided nerve block anesthesia + comprehensive nursing based on blind deblurring algorithm
Number of subjects: 50
Study 35720883 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation intravenous anesthesia + routine nursing
Number of subjects: 50
Study 34127559 — intervention group
Group type: COMPARATOR
Intervention: Pill splitting using own technique (Group A)
Number of subjects: 193
Study 34127559 — intervention group
Group type: EXPERIMENTAL
Intervention: Pill splitting using pill cutters after training (Group B)
Number of subjects: 193
Study 34127559 — intervention group
Group type: EXPERIMENTAL
Intervention: Pill splitting training (Group B)
Number of subjects: 193
Study 35845953 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-desflurane group (Group-SD)
Number of subjects: 60
Study 35845953 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane-only group (Group-S)
Number of subjects: 60
Study 33293172 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Dexamethasone
Number of subjects: 90
Study 33293172 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Dexamethasone
Number of subjects: 90
Study 33826431 — intervention group
Group type: EXPERIMENTAL
Intervention: Good adherence to DMTs
Number of subjects: 142
Study 33826431 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor adherence to DMTs
Number of subjects: 142
Study 33826431 — intervention group
Group type: COMPARATOR
Intervention: Non-adherence to DMTs
Number of subjects: 142
Study 33487564 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile, kinesthetic and oral stimulation (T + K + OS)
Number of subjects: 42
Study 33487564 — intervention group
Group type: COMPARATOR
Intervention: Oral stimulation (OS)
Number of subjects: 42
Study 33567018 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal SN6AD1 IOL
Number of subjects: 38
Study 33567018 — intervention group
Group type: COMPARATOR
Intervention: Aspheric monofocal SN60WF IOL
Number of subjects: 38
Study 34459448 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined enhanced instruction
Number of subjects: 311
Study 34459448 — intervention group
Group type: COMPARATOR
Intervention: Telephone reeducation
Number of subjects: 311
Study 34459448 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 311
Study 33655429 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Babies delivered via home visiting paraprofessionals
Number of subjects: 874
Study 33655429 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Babies delivered via mental health professionals
Number of subjects: 874
Study 33655429 — intervention group
Group type: COMPARATOR
Intervention: Usual community-based services (control)
Number of subjects: 874
Study 33046213 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of the dopaminergic antagonist amisulpride
Number of subjects: 131
Study 33046213 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of the opioidergic antagonist naltrexone
Number of subjects: 131
Study 33046213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 35657611 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Number of subjects: 69
Study 34369680 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-needle moxibustion (WNM)
Number of subjects: 84
Study 34369680 — intervention group
Group type: COMPARATOR
Intervention: Control (medication)
Number of subjects: 84
Study 35916933 — intervention group
Group type: EXPERIMENTAL
Intervention: 2+2 night shift (two consecutive night shifts followed by two consecutive recovery days)
Number of subjects: 17
Study 35916933 — intervention group
Group type: EXPERIMENTAL
Intervention: 4+4 night shift (four consecutive night shifts followed by four consecutive recovery days)
Number of subjects: 17
Study 35916933 — intervention group
Group type: EXPERIMENTAL
Intervention: 7+7 night shift (seven consecutive night shifts followed by seven consecutive recovery days)
Number of subjects: 17
Study 35916933 — intervention group
Group type: COMPARATOR
Intervention: Night shifts
Number of subjects: 17
Study 35916933 — intervention group
Group type: COMPARATOR
Intervention: Recovery days
Number of subjects: 17
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe AKI
Number of subjects: 900
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 3 AKI
Number of subjects: 900
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 3 AKI occurring 7 days before death
Number of subjects: 900
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraventricular hemorrhage
Number of subjects: 900
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis
Number of subjects: 900
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe AKI occurring 7 days before death
Number of subjects: 900
Study 34117080 — intervention group
Group type: EXPERIMENTAL
Intervention: Late severe AKI (after day 14 and before day 28)
Number of subjects: 900
Study 32456048 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Number of subjects: 14
Study 32456048 — intervention group
Group type: COMPARATOR
Intervention: Ankle stability exercise
Number of subjects: 14
Study 35944602 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary pain management program (3-week intervention)
Number of subjects: 103
Study 35944602 — intervention group
Group type: COMPARATOR
Intervention: Usual care (TAU)
Number of subjects: 103
Study 36129364 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk 'n Watch protocol
Number of subjects: 195
Study 36129364 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 195
Study 32563863 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-enriched fish oil (FO) 2 g/day (860 mg DHA + 120 mg EPA)
Number of subjects: 73
Study 32563863 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (CO) 2 g/day
Number of subjects: 73
Study 35440345 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass Prolonged Exposure (MPE) therapy
Number of subjects: 138
Study 35440345 — intervention group
Group type: COMPARATOR
Intervention: Standard Prolonged Exposure (SPE) therapy
Number of subjects: 138
Study 33904589 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to attachment‐based family therapy (ABFT)
Number of subjects: 118
Study 33904589 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to family‐enhanced nondirective supportive therapy (FE‐NST)
Number of subjects: 118
Study 33904589 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to attachment‐based family therapy (ABFT) with therapeutic alliance as a moderator
Number of subjects: 118
Study 33904589 — intervention group
Group type: COMPARATOR
Intervention: Adherence to family‐enhanced nondirective supportive therapy (FE‐NST) with therapeutic alliance as a moderator
Number of subjects: 118
Study 33403819 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary feeding behaviour change communication for 9 months
Number of subjects: 0
Study 33403819 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35916749 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up with core stability exercises (CORE)
Number of subjects: 15
Study 35916749 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up with elastic band exercises (ELAS)
Number of subjects: 15
Study 35916749 — intervention group
Group type: COMPARATOR
Intervention: Traditional warm-up (TRAD)
Number of subjects: 15
Study 34429646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine topical system 1.8% under swimming conditions
Number of subjects: 24
Study 34429646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine topical system 1.8% under showering conditions
Number of subjects: 24
Study 34429646 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine topical system 1.8% under normal conditions
Number of subjects: 24
Study 34429646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine topical system 1.8%
Number of subjects: 24
Study 32293533 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (n = 40)
Number of subjects: 120
Study 32293533 — intervention group
Group type: COMPARATOR
Intervention: Active control condition based on physical training (n = 40)
Number of subjects: 120
Study 32293533 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) control group (n = 40)
Number of subjects: 120
Study 35347080 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated continuous monitoring alert to initiate RT driven care
Number of subjects: 201
Study 35347080 — intervention group
Group type: COMPARATOR
Intervention: Standard RT assessment tool
Number of subjects: 201
Study 34313875 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication-focused grants
Number of subjects: 344
Study 32535601 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical movement activity and multifaceted cognitive training (24 sessions, twice a week)
Number of subjects: 70
Study 32535601 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 34536637 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid sugars (total liquid sugar, liquid glucose, liquid fructose, fructose from fruit juice)
Number of subjects: 7056
Study 34536637 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid sugars
Number of subjects: 7056
Study 33965876 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Regulated Learning
Number of subjects: 40
Study 33965876 — intervention group
Group type: COMPARATOR
Intervention: Activity-Based intervention
Number of subjects: 40
Study 32345760 — intervention group
Group type: EXPERIMENTAL
Intervention: VPes‐guided (PEEP tailored to equalize end‐expiratory transpulmonary pressure)
Number of subjects: 28
Study 36136436 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 302
Study 36136436 — intervention group
Group type: COMPARATOR
Intervention: Printed literature (control)
Number of subjects: 302
Study 33663889 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Assistance Scale scores and patient age
Number of subjects: 306
Study 33663889 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver gender and smoking status
Number of subjects: 306
Study 33663889 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver age
Number of subjects: 306
Study 33663889 — intervention group
Group type: EXPERIMENTAL
Intervention: Time (post‐surgery vs pre‐surgery)
Number of subjects: 306
Study 33663889 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient body mass index, patient and caregiver gender
Number of subjects: 306
Study 33663889 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient and caregiver employment status and caregiver education level
Number of subjects: 306
Study 32909356 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) by washed preparation
Number of subjects: 9
Study 35331700 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (with epinephrine 0.25%, 1:200,000)
Number of subjects: 50
Study 35331700 — intervention group
Group type: COMPARATOR
Intervention: Liposomal Bupivacaine (LipoB) 1.3%
Number of subjects: 50
Study 32931950 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil activation test (BAT) using shrimp extract as stimulant
Number of subjects: 35
Study 32931950 — intervention group
Group type: EXPERIMENTAL
Intervention: EXiLE test with shrimp extract and tropomyosin
Number of subjects: 35
Study 32931950 — intervention group
Group type: COMPARATOR
Intervention: Skin prick test (SPT)
Number of subjects: 35
Study 32931950 — intervention group
Group type: COMPARATOR
Intervention: Serum specific IgE (sIgE)
Number of subjects: 35
Study 33438008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod HCl 1 mg daily
Number of subjects: 197
Study 33438008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 36326985 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning exercise (AMEx; 0600-0900)
Number of subjects: 100
Study 36326985 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening exercise (PMEx; 1600-1900)
Number of subjects: 100
Study 36326985 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 100
Study 33981097 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anaesthesia
Number of subjects: 702
Study 33981097 — intervention group
Group type: COMPARATOR
Intervention: Peribulbar anaesthesia
Number of subjects: 702
Study 35195913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous liposomal irinotecan at 70 mg/m2
Number of subjects: 25
Study 33813009 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide application to the dermis
Number of subjects: 60
Study 33813009 — intervention group
Group type: COMPARATOR
Intervention: Standard skin preparation and antibiotic prophylaxis (Control)
Number of subjects: 60
Study 33813009 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Hydrogen peroxide and Control)
Number of subjects: 60
Study 34042178 — intervention group
Group type: EXPERIMENTAL
Intervention: learn-to-code
Number of subjects: 174
Study 34042178 — intervention group
Group type: EXPERIMENTAL
Intervention: mathematics
Number of subjects: 174
Study 34042178 — intervention group
Group type: COMPARATOR
Intervention: reading
Number of subjects: 174
Study 32645452 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard online ACP
Number of subjects: 570
Study 32645452 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive online ACP decision aid
Number of subjects: 570
Study 32645452 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 570
Study 35920880 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 80
Study 32759848 — intervention group
Group type: EXPERIMENTAL
Intervention: EAT: Eating As Treatment intervention
Number of subjects: 390
Study 32759848 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 390
Study 34543246 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-propofol-balanced anesthesia (BA group)
Number of subjects: 60
Study 34543246 — intervention group
Group type: COMPARATOR
Intervention: Propofol-based total intravenous anesthesia (TIVA group)
Number of subjects: 60
Study 34543246 — intervention group
Group type: COMPARATOR
Intervention: Comparison of BA vs TIVA
Number of subjects: 60
Study 32005286 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 2188
Study 32005286 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 2188
Study 35075551 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravenous dexamethasone (8 mg)
Number of subjects: 0
Study 35075551 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarticular injection of dexamethasone (8 mg)
Number of subjects: 0
Study 35075551 — intervention group
Group type: COMPARATOR
Intervention: Divided dose intravenous dexamethasone (two doses of 4 mg separated by 24 hours)
Number of subjects: 0
Study 35075551 — intervention group
Group type: COMPARATOR
Intervention: Single intravenous dose group
Number of subjects: 0
Study 35075551 — intervention group
Group type: COMPARATOR
Intervention: Interval dose group
Number of subjects: 0
Study 35075551 — intervention group
Group type: EXPERIMENTAL
Intervention: Single low-dose intravenous dexamethasone
Number of subjects: 0
Study 35075551 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarticular infiltration of low-dose dexamethasone
Number of subjects: 0
Study 35075551 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous dexamethasone
Number of subjects: 0
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fat overfeeding
Number of subjects: 38
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsaturated fat overfeeding
Number of subjects: 38
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar overfeeding
Number of subjects: 38
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall microbiota community structure
Number of subjects: 38
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of Desulfovibrionaceae and Bilophila
Number of subjects: 38
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: General microbiota signatures
Number of subjects: 38
Study 32536582 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriage of Bilophila
Number of subjects: 38
Study 32316995 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance Care (MC)
Number of subjects: 319
Study 32316995 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 319
Study 35021269 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1211 (3-3000 mg single dose)
Number of subjects: 96
Study 35021269 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1211 (10-300 mg once daily or 150 mg twice daily for 10 days)
Number of subjects: 96
Study 35021269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 35021269 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 days)
Number of subjects: 96
Study 33111530 — intervention group
Group type: EXPERIMENTAL
Intervention: High beverage advertisement receptivity
Number of subjects: 815
Study 33111530 — intervention group
Group type: EXPERIMENTAL
Intervention: Low beverage advertisement receptivity
Number of subjects: 815
Study 33111530 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived SSB harm
Number of subjects: 815
Study 32123978 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Port TEP (STEP)
Number of subjects: 99
Study 32123978 — intervention group
Group type: COMPARATOR
Intervention: Conventional Laparoscopic TEP (CTEP)
Number of subjects: 99
Study 33333200 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT) - 1 × 18 Gy, 3 × 10 Gy, or 5 × 7 Gy
Number of subjects: 110
Study 33333200 — intervention group
Group type: COMPARATOR
Intervention: Conventional Radiation Therapy (cRT) - 1 × 8 Gy, 5 × 4 Gy, or 10 × 3 Gy
Number of subjects: 110
Study 33333200 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 110
Study 33333200 — intervention group
Group type: COMPARATOR
Intervention: Conventional Radiation Therapy (cRT)
Number of subjects: 110
Study 35175209 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (adapted cognitive-behavioral stress management courses and regular physical activity promotion)
Number of subjects: 300
Study 35175209 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 300
Study 36194412 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin eye drops
Number of subjects: 88
Study 36194412 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 88
Study 36194412 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 88
Study 36194412 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotics (meta-analysis)
Number of subjects: 88
Study 36194412 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops (meta-analysis)
Number of subjects: 88
Study 33509626 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing faculty's knowledge of fundamental statistical concepts
Number of subjects: 164
Study 36235871 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwifruit
Number of subjects: 0
Study 36235871 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C Tablets
Number of subjects: 0
Study 36235871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32139513 — intervention group
Group type: EXPERIMENTAL
Intervention: TIDieR checklist adherence
Number of subjects: 101
Study 32139513 — intervention group
Group type: COMPARATOR
Intervention: Pre-TIDieR publication intervention reporting
Number of subjects: 101
Study 32139513 — intervention group
Group type: COMPARATOR
Intervention: Post-TIDieR publication intervention reporting
Number of subjects: 101
Study 32769914 — intervention group
Group type: EXPERIMENTAL
Intervention: NBP injection
Number of subjects: 0
Study 32769914 — intervention group
Group type: COMPARATOR
Intervention: NBP injection placebo
Number of subjects: 0
Study 33025678 — intervention group
Group type: EXPERIMENTAL
Intervention: Overexpression of LINC01089
Number of subjects: 2